Abstract:Translational medicine is known as biomedicine models with purpose of finding solutions for clinical challenges. The clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system makes impressive strides therein through gene knockout, knock‐in, activation, interference, base editing, and sequence detection, and continues to revolutionize the development of translational medicine. Translational medicine aims to improve human health by exploring potential treatment methods developed during basic scientific research and applying them to the treatment of patients in clinical settings. The advanced perceptions of gene functions have remarkably revolutionized clinical treatment strategies for target agents. However, the progress in gene editing therapy has been hindered due to the severe off‐target effects and limited editing sites. Fortunately, the development in the clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system has renewed hope for gene therapy field. The CRISPR‐Cas9 system can fulfill various simple or complex purposes, including gene knockout, knock‐in, activation, interference, base editing, and sequence detection. Accordingly, the CRISPR‐Cas9 system is adaptable to translational medicine, which calls for the alteration of genomic sequences. This review aims to present the latest CRISPR‐Cas9 technology achievements and prospect to translational medicine advances. The principle and characterization of the CRISPR‐Cas9 system are firstly introduced. The authors then focus on recent pre‐clinical and clinical research directions, including the construction of disease models, disease‐related gene screening and regulation, and disease treatment and diagnosis for multiple refractory diseases. Finally, some clinical challenges including off‐target effects, in vivo vectors, and ethical problems, and future perspective are also discussed.

The application and therapeutic potential of CRISPR/Cas9 technology in diseases

CRISPR/Cas9 therapeutics: progress and prospects

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

Development and application of CRISPR/Cas9 technologies in genomic editing.

The Applications of the CRISPR/Cas9 Gene-Editing System in Treating Human Diseases

Advances in Therapeutic Application of CRISPR-Cas9

CRISPR/Cas9 Mechanism and Applications Progression

Application and perspective of CRISPR/Cas9 genome editing technology in human diseases modeling and gene therapy

Therapeutic applications of CRISPR/Cas9 system in gene therapy

Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases

The application of CRISPR/Cas9 technology in infectious diseases

Application of CRISPR gene editing technology in cystic fibrosis treatment

Principle, application and prospect of CRISPR-Cas9 regulatory system

Research Progress in the Application of CRISPR/Cas9 Gene Editing Technology

The Application of CRISPR/Cas9 Technology in Neurological Diseases

The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research

New Advances of CRISPR/Cas9 Technique and its Application in Disease Treatment and Medicinal Plants Research

Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine